A phase 3 trial of cytisine as a smoking cessation aid

Trial Profile

A phase 3 trial of cytisine as a smoking cessation aid

Phase of Trial: Phase III

Latest Information Update: 10 Aug 2017

At a glance

  • Drugs Cytisine (Primary)
  • Indications Smoking withdrawal
  • Focus Therapeutic Use
  • Acronyms CASCAID
  • Most Recent Events

    • 10 Aug 2017 According to an Achieve Life Sciences media release, this trial was conceived by Dr. Natalie Walker, National Institute for Health Innovation, University of Auckland and funded by the Health Research Council of New Zealand.
    • 08 Mar 2017 According to an OncoGenex Pharmaceuticals media release, this trial was conducted by Dr. Walker.
    • 28 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top